Readystate Asset Management LP Johnson & Johnson Call Options Transaction History

Readystate Asset Management LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$145.48 - $167.38 $9.17 Million - $10.5 Million	63,000 Added 1145.45%	68,500 $11.1 Billion
Q2 2024 Aug 14, 2024	SELL	$144.38 - $157.78 $6.02 Million - $6.58 Million	-41,700 Reduced 88.35%	5,500 $804 Million
Q1 2024 May 10, 2024	BUY	$155.22 - $162.74 $3.52 Million - $3.69 Million	22,700 Added 92.65%	47,200 $7.47 Billion
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $3.57 Million - $3.89 Million	24,500 New	24,500 $3.84 Billion
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $302,100 - $360,520	2,000 New	2,000 $310 Million

4,271

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Readystate Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Readystate Asset Management LP with notifications on news.